title: Annexin VII as a novel marker for invasive phenotype of malignant melanoma.
abstract: Both F10 and BL6 sublines of B16 mouse melanoma cells are metastatic after intravenous injection, but only BL6 cells are metastatic after subcutaneous injection. While examining the genetic difference between the two sublines, we found a marked reduction of annexin VII expression in BL6 cells. In addition, fusion cell clones of both sublines were as poorly metastatic as F10 cells after subcutaneous injection, and contained the annexin VII message as abundantly as F10 cells. Hence, we examined whether the annexin VII expression was correlated with the less malignant phenotype of clinical cases by immunohistochemistry. Immunoreactivities to anti-annexin VII antibody in melanoma cells were evaluated quantitatively by using skin mast cells as an internal positive control. Eighteen patients with malignant melanoma were divided into two groups: lymph node metastasis-negative and positive groups. The ratio of numbers of patients positive versus negative to the antibody was significantly larger in the former than in the latter group. These results not only indicated that annexin VII serves as a marker for less invasive phenotype of malignant melanoma, but also suggested a possible role of annexin VII in tumor suppression.
authors.affiliation: Department of Pathology, Osaka University Medical School, Suita.
authors.forename: T R
authors.initials: TR
authors.lastname: Kataoka
authors.forename: A
authors.initials: A
authors.lastname: Ito
authors.forename: H
authors.initials: H
authors.lastname: Asada
authors.forename: K
authors.initials: K
authors.lastname: Watabe
authors.forename: K
authors.initials: K
authors.lastname: Nishiyama
authors.forename: K
authors.initials: K
authors.lastname: Nakamoto
authors.forename: S
authors.initials: S
authors.lastname: Itami
authors.forename: K
authors.initials: K
authors.lastname: Yoshikawa
authors.forename: M
authors.initials: M
authors.lastname: Ito
authors.forename: H
authors.initials: H
authors.lastname: Nojima
authors.forename: Y
authors.initials: Y
authors.lastname: Kitamura
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D017310:Annexin A7 / Q000096:biosynthesis* / Q000235:genetics; D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000235:genetics; D002459:Cell Fusion; D002460:Cell Line; D002648:Child; D018076:DNA, Complementary / Q000378:metabolism; D015536:Down-Regulation; D005260:Female; D015723:Gene Library; D005799:Genes, Dominant; D006801:Humans; D008297:Male; D008545:Melanoma / Q000378:metabolism*; D008546:Melanoma, Experimental; D051379:Mice; D008810:Mice, Inbred C57BL; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D012878:Skin Neoplasms / Q000378:metabolism; D013154:Spleen / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D017310:Annexin A7; D014408:Biomarkers, Tumor; D018076:DNA, Complementary; D012333:RNA, Messenger